UNCY
Unicycive Therapeutics Inc

2,988
Loading...
Loading...
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
22

Frequently Asked Questions

What is Market Cap of Unicycive Therapeutics Inc?
What is the 52-week high for Unicycive Therapeutics Inc?
What is the 52-week low for Unicycive Therapeutics Inc?
What is Unicycive Therapeutics Inc stock price today?
What was Unicycive Therapeutics Inc stock price yesterday?
What is the PE ratio of Unicycive Therapeutics Inc?
What is the Price-to-Book ratio of Unicycive Therapeutics Inc?
What is the 50-day moving average of Unicycive Therapeutics Inc?
How many employess does Unicycive Therapeutics Inc has?

Latest UNCY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.